Shreyas Joshi

Department of Urology
Assistant Professor

(404) 778-0495

Overview

After earning his MD degree from the Indiana University School of Medicine, Dr. Shreyas Joshi did his general surgery internship and urology residency at Vanderbilt University Medical Center. He completed his Society of Urologic Oncology Fellowship at Fox Chase Cancer Center in Philadelphia, and obtained his Master of Public Health at Temple University College of Public Health. Prior to joining Emory in 2019, Dr. Joshi was an attending surgeon at Fox Chase Center.

Dr. Joshi is the Director of the Bladder Cancer Program for Emory Urology. His clinical interests include the management of complex urologic malignancies, with particular specialization in open, laparoscopic, and robotic approaches to prostate, bladder, and kidney cancers, as well as the surgical management of other urologic cancers.

Dr. Joshi is a member and active participant in the American Urological Association and the Society of Urologic Oncology. He has published, contributed, and presented dozens of abstracts, articles, and book chapters on urologic cancers, and actively participates in major national clinical trials.

Academic Appointment

Assistant Professor - Department of Urology, Emory University Hospital

Education

Degrees

MPH from Temple University
MD from Indiana University School of Medicine

Research

Publications

Incidence of New Mental Health Diagnosis in Testicular Cancer Survivors.
Urology Volume: 200 Page(s): 135 - 141
06/01/2025 Authors: Marthi S; Palmateer G; Helman T; Patil D; Nicaise E; Goodstein T; Ogan K; Narayan V; Master V; Joshi SS
Patterns of telehealth use in newly diagnosed prostate cancer patients.
Urol Oncol
05/11/2025 Authors: Eyrich NW; Patil D; Marthi S; Sudderth SR; Andino JJ; Joshi SS; Filson CP
Trop-2 and Ephrin B2 expression in urothelial carcinoma with divergent differentiation and aggressive urothelial carcinoma subtypes.
Am J Clin Pathol Volume: 163 Page(s): 618 - 628
04/19/2025 Authors: Case KB; Martini DJ; Dababneh MN; Bidot S; Nazha B; Brown J; Joshi S; Narayan V; Parihar V; Saeed F
A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomy.
BJU Int Volume: 135 Page(s): 648 - 656
04/01/2025 Authors: de Jong JJ; Proudfoot JA; Daneshmand S; Svatek RS; Narayan V; Gibb EA; Davicioni E; Joshi S; Dahmen A; Li R
Utilization, health care expenditures, and patient costs of definitive treatment modalities for localized prostate cancer in the United States.
Cancer Volume: 131 Page(s): e35795
03/15/2025 Authors: Sebastian NT; Patil D; Patel PR; Jani AB; Hershatter BW; Dhere VR; Godette KD; Lorentz CA; Weiss AD; Joshi SS
Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical Cystectomy.
Eur Urol Open Sci Volume: 73 Page(s): 24 - 30
03/01/2025 Authors: de Jong JJ; Proudfoot JA; Daneshmand S; Svatek RS; Narayan V; Davicioni E; Joshi S; Dahmen A; Li R; Inman BA
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial.
Nat Cancer Volume: 6 Page(s): 432 - 444
03/01/2025 Authors: Bilen MA; Vo BT; Liu Y; Greenwald R; Davarpanah AH; McGuire D; Shiradkar R; Li L; Midya A; Nazha B
Characteristics, Treatment, and Outcomes of Primary Urethral Cancer: A Multicenter Review Over Two Decades.
Clin Genitourin Cancer Volume: 23 Page(s): 102276
02/01/2025 Authors: Hopkins BD; Qian DC; Xu KM; McCook-Veal A; Switchenko J; Hartsell LM; Cimmino CB; Joshi SS; Narayan V; Master VA
Paraneoplastic Syndrome Prevalence and Survival in Racially-Diverse Cohort With Renal Cell Carcinoma.
Clin Genitourin Cancer Volume: 22 Page(s): 102207
12/01/2024 Authors: Nicaise EH; Schmeusser BN; Palmateer G; Vashi K; Parikh K; Patil D; Shapiro DD; Abel EJ; Joshi S; Narayan V
Differentiation fate of a stem-like CD4 T cell controls immunity to cancer.
Nature Volume: 636 Page(s): 224 - 232
12/01/2024 Authors: Cardenas MA; Prokhnevska N; Sobierajska E; Gregorova P; Medina CB; Valanparambil RM; Greenwald R; DelBalzo L; Bilen MA; Joshi SS
PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiation.
Cancer Volume: 130 Page(s): 3658 - 3670
11/01/2024 Authors: Martini DJ; Case KB; Gratz D; Pellegrini K; Beagle E; Schneider T; Dababneh M; Nazha B; Brown JT; Joshi SS
Author Correction: Differentiation fate of a stem-like CD4 T cell controls immunity to cancer.
Nature Volume: 635 Page(s): E9
11/01/2024 Authors: Cardenas MA; Prokhnevska N; Sobierajska E; Gregorova P; Medina CB; Valanparambil RM; Greenwald R; DelBalzo L; Bilen MA; Joshi SS
Paraneoplastic Resolution Holds Prognostic Utility in Patients with Metastatic Renal Cell Carcinoma.
Cancers (Basel) Volume: 16
10/30/2024 Authors: Palmateer G; Nicaise EH; Goodstein T; Schmeusser BN; Patil D; Imtiaz N; Shapiro DD; Abel EJ; Joshi S; Narayan V
Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trial.
Res Sq
08/08/2024 Authors: Bilen MA; Vo BT; Liu Y; Greenwald R; Davarpanah AH; McGuire D; Shiradkar R; Li L; Nazha B; Brown JT
Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy.
Clin Genitourin Cancer Volume: 22 Page(s): 102056
06/01/2024 Authors: Nicaise EH; Schmeusser BN; Ali A; Midenberg E; Palacios AR; Hartsoe B; Kearns E; Ambadi S; Patil DH; Joshi SS
2018 Leibovich prognostic model for renal cell carcinoma: Performance in a large population with special consideration of Black race.
Cancer Volume: 130 Page(s): 453 - 466
02/01/2024 Authors: Schmeusser BN; Patil DH; Nicaise EH; Armas-Phan M; Nabavizadeh R; Narayan VM; Joshi SS; Ogan K; Osunkoya AO; Bilen MA
Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study.
Int Urol Nephrol Volume: 56 Page(s): 87 - 96
01/01/2024 Authors: Hafron J; Breyer BN; Joshi S; Smith C; Kaufman MR; Okonski J; Chancellor MB
Let's Be Practical: Home-based Moderate-intensity Exercise Interventions Are Needed.
Eur Urol Focus Volume: 10 Page(s): 6 - 7
01/01/2024 Authors: Parke S; Joshi S
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.
Oncologist Volume: 28 Page(s): 1072 - 1078
12/11/2023 Authors: Sanda GE; Shabto JM; Goyal S; Liu Y; Martini DJ; Nazha B; Brown JT; Yantorni LB; Anne Russler G; Caulfield S
Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.
Oncologist Volume: 28 Page(s): e1219 - e1229
12/11/2023 Authors: Schmeusser BN; Biermann H; Nicaise EH; Ali AA; Patil DH; Midenberg E; Helman T; Armas-Phan M; Nabavizadeh R; Joshi SS
Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE).
Eur Urol Volume: 84 Page(s): 361 - 370
10/01/2023 Authors: Surasi DS; Eiber M; Maurer T; Preston MA; Helfand BT; Josephson D; Tewari AK; Somford DM; Rais-Bahrami S; Koontz BF
Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.
Clin Genitourin Cancer Volume: 21 Page(s): 475 - 482.e4
08/01/2023 Authors: Schmeusser BN; Midenberg E; Palacios AR; Ali AA; Patil DH; Higgins M; Nabavizadeh R; Croll B; Williams M; Sheehy J
Prolonged Opioid Use Following Bladder Tumor Resection for Opioid-nave Patients.
Urol Pract Volume: 10 Page(s): 345 - 351
07/01/2023 Authors: Croll B; Patil D; Mason M; Narayan VM; Master V; Filson CP; Joshi SS
What's in a Name: An Analysis of Gender-Based Acronyms in Clinical Trials.
Ann Surg Oncol Volume: 30 Page(s): 2594 - 2596
05/01/2023 Authors: Bukavina L; Sindhani M; Joshi SS; Plimack E; Correa A; Uzzo N; Kutikov A; Uzzo R
Editorial Comment.
J Urol Volume: 209 Page(s): 888 - 889
05/01/2023 Authors: Croll B; Joshi SS
Clinicopathologic analysis of patients undergoing repeat transurethral resection of bladder tumour following an initial diagnosis of urothelial carcinoma with lamina propria invasion and variant/divergent histology.
Volume: 76 Page(s): 256 - 260
04/01/2023 Authors: Mullane P; Joshi S; Bilen M; Osunkoya AO
Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus 18F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial.
J Nucl Med Volume: 64 Page(s): 586 - 591
04/01/2023 Authors: Lawal IO; Jani AB; Adediran OA; Goyal S; Abiodun-Ojo OA; Dhere VR; Marcus CV; Joshi SS; Master VA; Patel PR
Impact of 18 F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy.
Clin Nucl Med Volume: 48 Page(s): e153 - e159
04/01/2023 Authors: Lawal IO; Marcus C; Schuster DM; Goyal S; Adediran OA; Dhere VR; Joshi SS; Abiodun-Ojo OA; Master VA; Patel PR
CD8+ Tcell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor.
Immunity Volume: 56 Page(s): 107 - 124.e5
01/10/2023 Authors: Prokhnevska N; Cardenas MA; Valanparambil RM; Sobierajska E; Barwick BG; Jansen C; Reyes Moon A; Gregorova P; delBalzo L; Greenwald R
Challenges and opportunities in the management of non-urothelial bladder cancers.
Cancer Treat Res Commun Volume: 34 Page(s): 100663
01/01/2023 Authors: Brown JT; Narayan VM; Joshi SS; Harik L; Jani AB; Bilen MA
Sarcopenia and systemic inflammation are associated with decreased survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
Cancer Volume: 128 Page(s): 2073 - 2084
06/01/2022 Authors: Khan AI; Psutka SP; Patil DH; Hong G; Williams MA; Bilen MA; Sekhar A; Kissick HT; Narayan VM; Joshi SS
Histopathologic findings in patients who have undergone blue light cystoscopy and bladder biopsy or transurethral resection: A contemporary clinicopathologic analysis of 100 cases.
Pathol Res Pract Volume: 234 Page(s): 153916
06/01/2022 Authors: Singh J; Farooq S; Joshi S; Osunkoya AO
Editorial Comment.
J Urol Volume: 207 Page(s): 980
05/01/2022 Authors: Croll B; Joshi SS
Editorial Comment.
J Urol Volume: 207 Page(s): 980 - 981
05/01/2022 Authors: Hacker Gessner K; Tan H-J
Editorial Commentary.
Urol Pract Volume: 9 Page(s): 228
05/01/2022 Authors: Donnenfeld SR; Joshi SS
RENAL FUNCTIONAL CHANGES AFTER CYSTECTOMY: WHO IMPROVES AND WHO DOES NOT?
Volume: 207 Page(s): E971 - E971
05/01/2022 Authors: Croll B; Patil D; Vashi K; Alemozaffar M; Master V; Filson C; Ogan K; Narayan V; Joshi S
A Contemporary Clinicopathologic Analysis of Primary Urothelial Carcinoma of the Urethra Without Concurrent Renal Pelvic, Ureteral, or Bladder Carcinoma.
Int J Surg Pathol Volume: 30 Page(s): 15 - 22
02/01/2022 Authors: Chen F; Joshi S; Carthon BC; Osunkoya AO
Editorial Comment.
J Urol Volume: 207 Page(s): 69
01/01/2022 Authors: Croll B; Joshi SS
Case report: Important considerations for a renal mass on a solitary kidney in an adult with history of childhood wilms tumor.
Front Oncol Volume: 12 Page(s): 971341
01/01/2022 Authors: Schmeusser BN; Palacios AR; Midenberg E; Nabavizadeh R; Master VA; Joshi SS
Clinic friendly estimation of muscle composition: Preoperative linear segmentation shows overall survival correlated with muscle mass in patients with nonmetastatic renal cell carcinoma.
Front Oncol Volume: 12 Page(s): 1068357
01/01/2022 Authors: Schmeusser BN; Midenberg E; Palacios AR; Vettikattu N; Patil DH; Medline A; Higgins M; Armas-Phan M; Nabavizadeh R; Joshi SS
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
Oncologist Volume: 26 Page(s): 1017 - 1025
12/01/2021 Authors: Martini DJ; Shabto JM; Goyal S; Liu Y; Olsen TA; Evans ST; Magod BL; Ravindranathan D; Brown JT; Yantorni L
Longitudinal impact of bladder cancer diagnosis on common psychiatric disorders.
Volume: 10 Page(s): 8412 - 8420
12/01/2021 Authors: Cooke IJ; Patil D; Bobrek K; Narayan V; Master V; Rapaport M; Filson CP; Joshi SS
Primary urothelial carcinoma of the ureter without concurrent renal pelvic or bladder carcinoma: A contemporary clinicopathologic analysis.
Volume: 226 Page(s): 153584
12/31/2021 Authors: Gutierrez CM; Carthon BC; Joshi S; Osunkoya AO
Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance.
J Nucl Med Volume: 62 Page(s): 1089 - 1096
08/01/2021 Authors: Abiodun-Ojo OA; Jani AB; Akintayo AA; Akin-Akintayo OO; Odewole OA; Tade FI; Joshi SS; Master VA; Fielder B; Halkar RK
Small-Cell Carcinoma of the Prostate: Report of Outcomes of Localized Disease Using the National Cancer Database.
Clin Genitourin Cancer Volume: 19 Page(s): e193 - e199
08/01/2021 Authors: Xu KM; Liu Y; Gillespie TW; Osunkoya AO; Carthon B; Bilen MA; Filson CP; Ogan K; Patel PR; Shelton JW
A Helpful Tool in the Renal Surgery Armamentarium: Dorsal Lumbotomy nephrectomy for Tumor in Patients with End-Stage Renal Disease.
Urology Volume: 153 Page(s): 327 - 332
07/01/2021 Authors: Cooke I; Sadruddin S; Patil D; Tripathi S; Nabavizadeh R; Joshi S; Narayan V; Ogan K; Master VA
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
J Immunother Cancer Volume: 9
07/01/2021 Authors: Brown JT; Liu Y; Shabto JM; Martini D; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni L; Joshi SS
Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.
Cancer Volume: 127 Page(s): 1974 - 1983
06/15/2021 Authors: Higgins MI; Martini DJ; Patil DH; Nabavizadeh R; Steele S; Williams M; Joshi SS; Narayan VM; Sekhar A; Psutka SP
18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial.
Lancet Volume: 397 Page(s): 1895 - 1904
05/22/2021 Authors: Jani AB; Schreibmann E; Goyal S; Halkar R; Hershatter B; Rossi PJ; Shelton JW; Patel PR; Xu KM; Goodman M
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
Oncologist Volume: 26 Page(s): 397 - 405
05/01/2021 Authors: Brown JT; Liu Y; Shabto JM; Martini DJ; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni LB; Joshi SS
Minimizing opioid consumption following robotic surgery.
Transl Androl Urol Volume: 10 Page(s): 2289 - 2296
05/01/2021 Authors: Talwar R; Joshi SS
Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study.
Urol Oncol Volume: 39 Page(s): 296.e21 - 296.e29
05/01/2021 Authors: Marra G; Karnes RJ; Calleris G; Oderda M; Alessio P; Palazzetti A; Battaglia A; Pisano F; Munegato S; Munoz F
Clinicopathologic Implications of Unifocal vs Multifocal Invasive Urothelial Carcinoma of the Bladder with Lamina Propria Invasion
Volume: 34 Page(s): 589 - 589
03/01/2021 Authors: Mullane P; Joshi S; Bilen M; Osunkoya AO
Primary Urothelial Carcinoma of the Urethra Without Concurrent Renal Pelvic, Ureteral or Bladder Carcinoma: A Contemporary Clinicopathologic Analysis
Volume: 101 Page(s): 545 - 545
03/01/2021 Authors: Chen F; Joshi S; Carthon B; Osunkoya AO
Primary Urothelial Carcinoma of the Urethra Without Concurrent Renal Pelvic, Ureteral or Bladder Carcinoma: A Contemporary Clinicopathologic Analysis
Volume: 34 Page(s): 545 - 545
03/01/2021 Authors: Chen F; Joshi S; Carthon B; Osunkoya AO
Primary Urothelial Carcinoma of the Ureter without Concomitant Renal Pelvic or Bladder Carcinoma: A Contemporary Clinicopathologic Analysis
Volume: 34 Page(s): 561 - 561
03/01/2021 Authors: Gutierrez C; Carthon B; Joshi S; Osunkoya AO
Clinicopathologic Implications of Unifocal vs Multifocal Invasive Urothelial Carcinoma of the Bladder with Lamina Propria Invasion
Volume: 101 Page(s): 589 - 589
03/01/2021 Authors: Mullane P; Joshi S; Bilen M; Osunkoya AO
Primary Urothelial Carcinoma of the Ureter without Concomitant Renal Pelvic or Bladder Carcinoma: A Contemporary Clinicopathologic Analysis
Volume: 101 Page(s): 561 - 561
03/01/2021 Authors: Gutierrez C; Carthon B; Joshi S; Osunkoya AO
Editorial Comment.
J Urol Volume: 205 Page(s): 83 - 84
01/01/2021 Authors: Nabavizadeh R; Joshi SS
Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database.
Clin Transl Radiat Oncol Volume: 26 Page(s): 30 - 34
01/01/2021 Authors: Janopaul-Naylor JR; Zhong J; Liu Y; Zhang C; Osunkoya AO; Joshi SS; Bilen MA; Carthon B; Kucuk O; Hartsell LM
Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis.
Clin Genitourin Cancer Volume: 18 Page(s): e723 - e729
12/01/2020 Authors: Patel SH; Uzzo RG; Larcher A; Peyronnet B; Lane BR; Pruthi D; Reddy M; Capitanio U; Joshi S; Noyes S
Initial Report of a Randomized Trial Comparing Conventional- vs Conventional plus Fluciclovine (18F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer.
Volume: 108 Page(s): 1397
12/01/2020 Authors: Jani A; Schreibmann E; Goyal S; Raghuveer H; Hershatter B; Rossi PJ; Shelton JW; Patel PR; Xu KM; Goodman M
Bladder Preserving Chemoradiotherapy Compared To Surgery For Variants Of Urothelial Carcinoma And Tumors With Divergent Differentiation: An Analysis Of The National Cancer Database
Volume: 108 Page(s): E887 - E888
11/01/2020 Authors: Janopaul-Naylor J; Zhong J; Liu Y; Zhang C; Osunkoya AO; Joshi SS; Bilen MA; Carthon B; Kucuk O; Hartsell LM
Reply by Authors.
J Urol Volume: 204 Page(s): 536 - 537
09/01/2020 Authors: Geynisman DM; Kadow BT; Shuch BM; Boorjian SA; Matin SF; Rampersaud E; Milestone BN; Plimack ER; Zibelman MR; Kutikov A
Sporadic Angiomyolipomas Growth Kinetics While on Everolimus: Results of a Phase II Trial.
J Urol Volume: 204 Page(s): 531 - 537
09/01/2020 Authors: Geynisman DM; Kadow BT; Shuch BM; Boorjian SA; Matin SF; Rampersaud E; Milestone BN; Plimack ER; Zibelman MR; Kutikov A
Reply to Obesity and aggressive prostate cancer and the golden rule: Do not do to others what you do not want done to yourself.
Cancer Volume: 126 Page(s): 2322 - 2323
05/15/2020 Authors: Joshi SS; Filson CP
Editorial Comment.
J Urol Volume: 203 Page(s): 1001 - 1002
05/01/2020 Authors: Cooke IJ; Joshi SS
Re: Treatment Trends and Outcomes for Patients with Lymph Node-Positive Cancer of the Penis.
J Urol Volume: 203 Page(s): 879 - 880
05/01/2020 Authors: Chang SS
Editorial Comment.
J Urol Volume: 203 Page(s): 511
03/01/2020 Authors: Nabavizadeh R; Joshi SS
Association of modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (CPI)
Volume: 38
02/20/2020 Authors: Brown JT; Liu Y; Martini DJ; Shabto JM; Hitron E; Russler G; Caulfield S; Yantorni LB; Joshi SS; Kissick H
Association of baseline modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic urothelial cell carcinoma (mUCC) treated with immune checkpoint inhibitors (CPI)
Volume: 38
02/20/2020 Authors: Brown JT; Liu Y; Shabto JM; Martini DJ; Ravindranathan D; Hitron E; Russler G; Caulfield S; Yantorni LB; Joshi SS
Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening.
Cancer Volume: 126 Page(s): 694 - 696
02/15/2020 Authors: Joshi SS; Filson CP
Treatment Facility Volume and Survival in Patients with Advanced Prostate Cancer.
Eur Urol Oncol Volume: 3 Page(s): 104 - 111
02/01/2020 Authors: Joshi SS; Handorf ER; Sienko D; Zibelman M; Uzzo RG; Kutikov A; Horwitz EM; Smaldone MC; Geynisman DM
The volume-outcome relationship in kidney cancer: is more really better?
Ann Transl Med Volume: 7 Page(s): S336
12/01/2019 Authors: Kadow BT; Joshi SS; Kutikov A; Handorf E; Smaldone MC; Uzzo RG; Geynisman DM
Prediction of significant estimated glomerular filtration rate decline after renal unit removal to aid in the clinical choice between radical and partial nephrectomy in patients with a renal mass and normal renal function.
BJU Int Volume: 124 Page(s): 999 - 1005
12/01/2019 Authors: McIntosh AG; Parker DC; Egleston BL; Uzzo RG; Haseebuddin M; Joshi SS; Viterbo R; Greenberg RE; Chen DYT; Smaldone MC
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches.
J Urol Volume: 202 Page(s): 725 - 731
10/01/2019 Authors: Gontero P; Marra G; Alessio P; Filippini C; Oderda M; Munoz F; Linares E; Sanchez-Salas R; Challacombe B; Dasgupta P
Editorial Comment.
J Urol Volume: 201 Page(s): 949
05/01/2019 Authors: Srivastava A; Joshi SS
Editorial Comment.
Urology Volume: 124 Page(s): 165 - 167
02/01/2019 Authors: Joshi SS; Uzzo RG
Renal Hilar Lesions: Biological Implications for Complex Partial Nephrectomy.
Urology Volume: 123 Page(s): 174 - 180
01/01/2019 Authors: Correa AF; Yankey H; Li T; Joshi SS; Kutikov A; Chen DY; Viterbo R; Greenberg RE; Smaldone MC; Uzzo RG
Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis.
Eur Urol Volume: 74 Page(s): 387 - 393
09/01/2018 Authors: Joshi SS; Handorf EA; Zibelman M; Plimack ER; Uzzo RG; Kutikov A; Smaldone MC; Geynisman DM
What can the National Cancer Database tell us about disparities in advanced bladder cancer outcomes?
Transl Androl Urol Volume: 7 Page(s): 732 - 735
08/01/2018 Authors: Joshi SS; Handorf ER; Smaldone MC; Geynisman DM
Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies.
Mol Cancer Ther Volume: 17 Page(s): 1355 - 1364
07/01/2018 Authors: Makhov P; Joshi S; Ghatalia P; Kutikov A; Uzzo RG; Kolenko VM
Treatment Trends and Outcomes for Patients With Lymph Node-Positive Cancer of the Penis.
JAMA Oncol Volume: 4 Page(s): 643 - 649
05/01/2018 Authors: Joshi SS; Handorf E; Strauss D; Correa AF; Kutikov A; Chen DYT; Viterbo R; Greenberg RE; Uzzo RG; Smaldone MC
Differences in Survival Associated with Performance of Lymph Node Dissection inPatients with Invasive Penile Cancer: Results from the National Cancer Database.
J Urol Volume: 199 Page(s): 1238 - 1244
05/01/2018 Authors: Correa AF; Handorf E; Joshi SS; Geynisman DM; Kutikov A; Chen DY; Uzzo RG; Viterbo R; Greenberg RE; Smaldone MC
USING ADT-FREE SURVIVAL TO EVALUATE THE UTILITY OF SALVAGE CRYOABLATION IN MEN WITH LOCALLY RECURRENT PROSTATE CANCER AFTER RADIATION
Volume: 199 Page(s): E655 - E655
04/01/2018 Authors: Joshi S; Strauss D; Correa A; Cahn D; Kadow B; Greenberg R; Viterbo R; Smaldone M; Kutikov A; Uzzo R
IMPACT OF PRE-EXSISTING DIABETES MELLITUS ON SURVIVAL IN STAGE I RENAL CELL CARCINOMA
Volume: 199 Page(s): E543 - E543
04/01/2018 Authors: Ryan S; Bindayi A; Uzzo R; Bloch A; Reddy M; Hamilton Z; Nasseri R; Yim K; Wan F; Capitanio U
COMPLICATIONS AND FUNCTIONAL OUTCOMES OF SALVAGE RADICAL PROSTATECTOMY: A COMPARISON BETWEEN OPEN AND ROBOT-ASSISTED APPROACHES IN A MULTICENTRE SERIES
Volume: 199 Page(s): E568 - E569
04/01/2018 Authors: Gontero P; Marra G; Alessio P; Oderda M; Palazzetti A; Pisano F; Battaglia A; Munegato S; Frea B; Munoz F
COMPARATIVE ANALYSIS OF OUTCOMES OF PAPILLARY TYPE 1 AND TYPE 2 AND CLEAR CELL RENAL CELL CARCINOMA: A MULTI-INSTITUTIONAL STUDY
Volume: 199 Page(s): E356 - E357
04/01/2018 Authors: Bindayi A; Joshi S; Larcher A; Reddy M; Ryan S; Capitanio U; Hamilton Z; Yim K; Noyes S; Dey S
ONCOLOGICAL OUTCOMES OF SALVAGE RADICAL PROSTATECTOMY IN A CONTEMPORARY, MULTICENTRE SERIES OF 395 CASES
Volume: 199 Page(s): E128 - E129
04/01/2018 Authors: Gontero P; Marra G; Alessio P; Oderda M; Palazzetti A; Pisano F; Battaglia A; Munegato S; Calleris G; Frea B
KIDNEY CANCER WELLNESS DETERMINANT (KCWD) AN ADJUNCTIVE TOOL TO PREDICT SURVIVAL IN RENAL CELL CARCINOMA
Volume: 199 Page(s): E364 - E364
04/01/2018 Authors: Bindayi A; Bloch A; Hamilton Z; Joshi S; Reddy M; Ryan S; Nasseri R; Uzzo R; Derweesh I
USEFULNESS OF PRE-SALVAGE RADICAL PROSTATECTOMY PROSTATE BIOPSIES: DO THEY RIGHTLY PREDICT THE FINAL HISTOLOGY?
Volume: 38 Page(s): 2566 - 2567
04/01/2018 Authors: Marra G; Alessio P; Oderda M; Palazzetti A; Pisano F; Battaglia A; Munegato S; Marquis A; Tappero S; Frea B
RADICAL PROSTATECTOMY IN A SALVAGE SETTING: RESULTS OF A CONTEMPORARY MULTICENTRE SERIES OF 395 CASES
Volume: 38 Page(s): 2565 - 2566
04/01/2018 Authors: Marra G; Alessio P; Oderda M; Palazzetti A; Pisano F; Battaglia A; Munegato S; Frea B; Gontero P; Munoz F
OPEN VERSUS ROBOT-ASSISTED SALVAGE RADICAL PROSTATECTOMY: FUNCTIONAL OUTCOMES AND COMPLICATIONS OF A MULTICENTRE STUDY
Volume: 38 Page(s): 2564 - 2565
04/01/2018 Authors: Marra G; Oderda M; Alessio P; Palazzetti A; Pisano F; Battaglia A; Munegato S; Frea B; Gontero P; Munoz F
Perioperative Statin Use and Acute Kidney Injury in Patients Undergoing Partial Nephrectomy.
Kidney Cancer Volume: 2 Page(s): 47 - 55
03/30/2018 Authors: Joshi SS; Ruth K; Smaldone MC; Chen DYT; Greenberg RE; Viterbo R; Kutikov A; Uzzo RG
Effects of tumor size and location on survival in upper tract urothelial carcinoma after nephroureterectomy.
Indian J Urol Volume: 34 Page(s): 68 - 73
01/01/2018 Authors: Joshi SS; Quast LL; Chang SS; Patel SG
Understanding Mutational Drivers of Risk: An Important Step Toward Personalized Care for Patients with Renal Cell Carcinoma.
Eur Urol Focus Volume: 3 Page(s): 428 - 429
10/01/2017 Authors: Joshi S; Kutikov A
Renal Tumor Anatomic Complexity: Clinical Implications for Urologists.
Urol Clin North Am Volume: 44 Page(s): 179 - 187
05/01/2017 Authors: Joshi SS; Uzzo RG
OPEN VERSUS ROBOT-ASSISTED SALVAGE RADICAL PROSTATECTOMY: FUNCTIONAL OUTCOMES AND COMPLICATIONS OF A MULTICENTRE SERIES
Volume: 37 Page(s): 2144 - 2145
04/01/2017 Authors: Gontero P; Marra G; Alessio P; Oderda M; Palazzetti A; Pisano F; Battaglia A; Munegato S; Calleris G; Frea B
ONCOLOGICAL OUTCOMES IN A MULTICENTRE SERIES OF 243 SALVAGE RADICAL PROSTATECTOMIES
Volume: 37 Page(s): 2145 - 2146
04/01/2017 Authors: Marra G; Gontero P; Alessio P; Oderda M; Palazzetti A; Pisano F; Battaglia A; Munegato S; Calleris G; Frea B
OPEN VERSUS ROBOT-ASSISTED SALVAGE RADICAL PROSTATECTOMY: A COMPARISON OF ONCOLOGICAL OUTCOMES IN A RETROSPECTIVE MULTICENTRE SERIES
Volume: 37 Page(s): 2146 - 2147
04/01/2017 Authors: Marra G; Gontero P; Alessio P; Oderda M; Palazzetti A; Pisano F; Battaglia A; Munegato S; Frea B; Munoz F
COMPARISON OF ONCOLOGICAL OUTCOMES BETWEEN OPEN VERSUS ROBOT-ASSISTED SALVAGE RADICAL PROSTATECTOMY: A RETROSPECTIVE MULTICENTRE SERIES
Volume: 197 Page(s): E1236 - E1236
04/01/2017 Authors: Gontero P; Marra G; Alessio P; Oderda M; Palazzetti A; Pisano F; Battaglia A; Munegato S; Frea B; Munoz F
NEOADJUVANT CHEMOTHERAPY FOR ELDERLY PATIENTS WITH LOCALLY ADVANCED OR EARLY NODAL DISEASE: ARE WE DOING ENOUGH?
Volume: 197 Page(s): E1195 - E1195
04/01/2017 Authors: Correa A; Handorf E; Ristau B; Haifler H; Joshi S; Uzzo R; Viterbo R; Greenberg R; Chen D; Kutikov A
TREATMENT TRENDS AND OUTCOMES FOR LYMPH NODE POSITIVE PENILE CANCER PATIENTS
Volume: 197 Page(s): E1088 - E1088
04/01/2017 Authors: Joshi S; Elizabeth H; Correa A; Haifler M; Ristau B; Uzzo R; Greenberg R; Chen D; Viterbo R; Kutikov A
CAN LOOKS DECEIVE? NOT ALL CLINICALLY "CYSTIC" RENAL MASSES HARBOR INDOLENT BIOLOGY
Volume: 197 Page(s): E992 - E992
04/01/2017 Authors: Ristau B; DeMora L; Ross E; Lee R; Haifler M; Joshi S; Correa A; Chen D; Greenberg R; Viterbo R
SURVIVAL ANALYSIS OF PATIENTS WITH T2 PENILE CANCER WHO RECEIVED INGUINAL LYMPH NODE DISSECTION: RESULTS FROM THE NATIONAL CANCER DATABASE
Volume: 197 Page(s): E977 - E977
04/01/2017 Authors: Correa A; Handorf E; Ristau B; Haifler H; Joshi S; Uzzo R; Viterbo R; Greenberg R; Chen D; Kutikov A
ONCOLOGICAL OUTCOMES OF SALVAGE RADICAL PROSTATECTOMY: A MULTICENTRE SERIES OF 243 PATIENTS
Volume: 197 Page(s): E844 - E845
04/01/2017 Authors: Marra G; Gontero P; Alessio P; Oderda M; Brattoli M; Calleris G; Palazzetti A; Pisano F; Battaglia A; Munegato S
VALIDATION OF A MATHEMATICAL MODEL TO PREDICT RENAL FUNCTION AFTER NEPHRON SPARING SURGERY
Volume: 197 Page(s): E785 - E785
04/01/2017 Authors: Haifler M; Higgins A; Ristau B; Correa A; Joshi S; Greenberg R; Chen D; Kutikov A; Viterbo R; Zisman A
CLASSIFICATION OF KIDNEY TUMORS WITH 1064 NM DISPERSIVE RAMAN SPECTROSCOPY
Volume: 197 Page(s): E704 - E704
04/01/2017 Authors: Haifler M; Pence I; Ristau B; Correa A; Joshi S; Greenberg R; Chen D; Smaldone M; Kutikov A; Viterbo R
SYSTEMIC THERAPY AND OVERALL SURVIVAL TRENDS IN PATIENTS WITH NON-UROTHELIAL HISTOLOGIC VARIANTS OF MUSCLE INVASIVE BLADDER CANCER UNDERGOING RADICAL CYSTECTOMY
Volume: 197 Page(s): E115 - E116
04/01/2017 Authors: Joshi S; Handorf E; Correa A; Ristau B; Haifler M; Uzzo R; Greenberg R; Chen D; Viterbo R; Kutikov A
Editorial Comment.
J Urol Volume: 197 Page(s): 307
02/01/2017 Authors: Joshi SS; Chen DYT
Editorial Comment.
J Urol Volume: 197 Page(s): 383 - 384
02/01/2017 Authors: Joshi S; Kutikov A
TREATMENT OF PRIAPISM IN THE EMERGENCY DEPARTMENT PRIOR TO UROLOGIC SURGERY CONSULTATION: A CONTEMPORARY EXPERIENCE AT A SINGLE INSTITUTION
Volume: 193 Page(s): E44 - E44
04/01/2015 Authors: Green E; Kappa S; Joshi S; Kaufman M; Milam D
FUNCTIONAL OUTCOMES AND FOLLOW-UP CARE AFTER PRIAPISM TREATMENT: A CONTEMPORARY EXPERIENCE AT A SINGLE INSTITUTION
Volume: 193 Page(s): E42 - E42
04/01/2015 Authors: Kappa S; Green E; Joshi S; Kaufman M; Milam D
MANAGEMENT OF PRIAPISM SECONDARY TO LEUKEMIA BLAST CRISIS IN LEUKEMIA: REVIEW OF 2 CASES AT A SINGLE INSTITUTION
Volume: 11 Page(s): 202 - 203
04/01/2014 Authors: Joshi S; Kappa S; Milam D
SPONTANEOUS DESCENT RATE OF CRYPTORCHID TESTES: A PLEA FOR EARLY REFERRAL
Volume: 191 Page(s): E251 - E251
04/01/2014 Authors: Joshi SS; Clayton DB; Pope JC; Adams MC; Tanaka ST; Brock JW; Thomas JC
SURVEILLANCE IMAGING AFTER T1 RCC: AN OVER-UTILIZATION OR NECESSARY CARE?
Volume: 191 Page(s): E111 - E112
04/01/2014 Authors: Joshi SS; Clark PE; Barocas DA; Sun D; Cookson MS; Resnick MJ; Smith JA; Chang SS
PRIAPISM: REVIEW OF ETIOLOGIES AND MANAGEMENT OF 79 CASES AT A SINGLE INSTITUTION
Volume: 11 Page(s): 151 - 151
04/01/2014 Authors: Kappa S; Joshi S; Milam D
Small bowel injury during laparoendoscopic single-site surgery for simple nephrectomy.
JSLS Volume: 17 Page(s): 167 - 169
01/01/2013 Authors: Joshi SS; Sundaram CP
Robotics training program: evaluation of the satisfaction and the factors that influence success of skills training in a resident robotics curriculum.
J Endourol Volume: 25 Page(s): 1669 - 1674
10/01/2011 Authors: Lucas SM; Gilley DA; Joshi SS; Gardner TA; Sundaram CP
Biochemical characterization of a regulatory cascade controlling transcription of the Pseudomonas aeruginosa type III secretion system.
J Biol Chem Volume: 282 Page(s): 6136 - 6142
03/02/2007 Authors: Zheng Z; Chen G; Joshi S; Brutinel ED; Yahr TL; Chen L

Directory section navigation

Profile